FDA Clearance Tracker · P970043-S025
LADARVISION 4000 EXCIMER LASER SYSTEM AND THE LADAR 6000 EXCIMER LASER SYSTEM
Last checked: Nov 20, 2026Latest source record: Jul 5, 2006 (this decision)Source: openFDAMethods & limitations
Decided
Jul 5, 2006
Approved
Time to decision
154 days
Received Feb 1, 2006. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P970043-S025
- Device name
- LADARVISION 4000 EXCIMER LASER SYSTEM AND THE LADAR 6000 EXCIMER LASER SYSTEM
- Applicant
- Alcon Laboratories
- Applicant location
- Fort Worth, TX
- Received
- Feb 1, 2006
- Decided
- Jul 5, 2006
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P970043
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR AN EXPANSION OF THE ALLOWABLE RANGE FOR THE PHYSICIAN ADJUSTMENT OF DEFOCUS OFFSET PARAMETER FOR THE WAVEFRONT-GUIDED MYOPIA AND MYOPIC ASTIGMATISM INDICATIONS FROM +=0.75 D TO UP TO 1.00 D INCREASE (MORE MYOPIC TREATMENT) AND UP TO 2.50 D DECREASE (LESS MYOPIC TREATMENT).
Source documents
Other decisions for Alcon Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K254052 · Decided Feb 13, 2026 · 58 days after receipt
Device type: Lenses, Soft Contact, Daily Wear (LPL) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.